𝔖 Bobbio Scriptorium

✦ LIBER ✦

Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis

✍ Scribed by Rukmini Rajagopalan; Robert S. Rosenson; Ancilla W. Fernandes; Mehmood Khan; Frederick T. Murray

Book ID: 116371670
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 884 KB
Volume: 26
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2004.09.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of developing coronary artery d

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

✍ Kevin M. Pantalone; Michael W. Kattan; Changhong Yu; Brian J. Wells; Susana Arri 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 286 KB

Pantalone et al.: The risk of developing

Pantalone et al.: The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

✍ David S. H. Bell 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 75 KB

Comparison of medication adherence and a

Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: A retrospective data analysis

✍ Rahul A. Shenolikar; Rajesh Balkrishnan; Fabian T. Camacho; J. Timothy Whitmire; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 765 KB

The relationship between nonfasting and

The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

✍ Robert Weiss; Melinda Harder; Jonathan Rowe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 602 KB

PDB25 COST OF ALL-CAUSE AND CARDIOVASCUL

PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN: A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE

✍ J.H. Best; E. Pelletier; D.B. Smith 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Letter to the Editor re: the Letter to t

Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis”

✍ Robert S. Zimmerman; Kevin Matthew Pantalone 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 82 KB